Prot# ECOG PCO-RL: E3503: A Pilot Study to Determine if Downstream Markers of EGFR Linked Signaling Pathways Predict Response to OSR-774 (Erlotinib) in the First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer